Industry News (Joint Venture)

Gene Expression Database Under Expanded Collaboration

Published in Gene Therapy Weekly, April 6th, 1998

Affymetrix, Inc., Santa Clara, California, and Oncormed, Inc., Gaithersburg, Maryland, announced that they have planned to co-develop a gene expression database as a tool to enable the use of gene expression data in drug development by third party subscribers.

The agreement further leverages Oncormed's strengths in gene characterization and pharmacogenomics with Affymetrix' GeneChip expression analysis tools. The latest collaboration is the third in a series of agreements between the companies, representing a relationship that began with the development and validation of a GeneChip assay for identifying mutations in the p53 gene.

Under the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1998-04-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry